NEW YORK (GenomeWeb News) - Beckman Coulter today said third-quarter revenues increased 6 percent as strong sales for its clinical diagnostics were offset by lower-than-expected sales for its life science products.
 
Total receipts for the three months ended Sept. 30 increased to $669 million from $631.2 million year over year.
 
The company said it saw an increase of 9.4 percent in clinical diagnostics, while life science products declined 8.6 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.